Moderne Makuladiagnostik an praktischen Beispielen



Derzeit befindet sich die makuläre Diagnostik, gleichzeitig aber auch die Therapie vieler makulärer Erkrankungen in einer Umbruchphase. Neben der Einführung und Verbreitung verfeinerter makulärer Funktionstests, sowohl einerseits subjektiver Prüfverfahren (u. a. automatisierte Mikroperimetrie [z. B. MP-1/FA Nidek; ◘ Abb. 7.1 und 7.2)] oder Preferential hyperacuity Perimetrie [PHP/FA Zeiss; Foresee PHP/FA Reichert]) als auch andererseits objektiver makulärer Funktionstestung (z. B. multifokales ERG) hat vor allem die Entwicklung neuer Funduskameratechniken (wie hochsensitiver Laserscanning-Systeme mit Eye-Tracking und verbesserter digitaler Bildbearbeitung) und die Einführung der optischen Kohärenztomographie (OCT) die retinologische Routinediagnostik stark verändert.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Charbel IP, Finger RP, Holz FG, Scholl HP (2009) Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci 50: 5913–5918CrossRefGoogle Scholar
  2. Chong GT, Farsiu S, Freedman SF et al. (2009) Abnormal foveal morphology in ocular albinism imaged with spectral-domain optical coherence tomography. Arch Ophthalmol 127: 37–44PubMedCrossRefGoogle Scholar
  3. Delori FC (2004) Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys 430: 156–162PubMedCrossRefGoogle Scholar
  4. Eldred GE, Lasky MR (1993) Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature 361: 724–726PubMedCrossRefGoogle Scholar
  5. Forooghian F, Stetson PF, Meyer SA et al. (2010) Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema. Retina 30: 63–70PubMedCrossRefGoogle Scholar
  6. Gelisken F, Ziemssen F (2010) Diabetic maculopathy. Diagnosis and treatment. Ophthalmologe 107: 773–786PubMedCrossRefGoogle Scholar
  7. Georgopoulos M, Geitzenauer W, Ahlers C, Simader C, Scholda C, Schmidt-Erfurth U (2008) High-resolution optical coherence tomography to evaluate vitreomacular traction before and after membrane peeling. Ophthalmologe 105: 753–760PubMedCrossRefGoogle Scholar
  8. Haller JA, Qin H, Apte RS et al. (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117: 1087–1093PubMedCrossRefGoogle Scholar
  9. Hammer M, Vilser W, Riemer T et al. (2011) Retinal venous oxygen saturation increases by flicker light stimulation. Invest Ophthalmol Vis Sci 52: 274–277PubMedCrossRefGoogle Scholar
  10. Hardarson SH, Harris A, Karlsson RA et al. (2006) Automatic retinal oximetry. Invest Ophthalmol Vis Sci 47: 5011–5016PubMedCrossRefGoogle Scholar
  11. Hardarson SH, Stefansson E (2010) Oxygen saturation in central retinal vein occlusion. Am J Ophthalmol 150: 871–875PubMedCrossRefGoogle Scholar
  12. Hassenstein A, Spital G, Scholz F, Henschel A, Richard G, Pauleikhoff D (2009) Optical coherence tomography for macula diagnostics. Review of methods and standardized application concentrating on diagnostic and therapy control of age-related macula degeneration. Ophthalmologe 106: 116–126PubMedCrossRefGoogle Scholar
  13. Heimes B, Lommatzsch A, Zeimer M et al. (2010) Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection scheme. Graefes Arch Clin Exp Ophthalmol 249: 639–644PubMedCrossRefGoogle Scholar
  14. Heimes B, Lommatzsch A, Zeimer M, Gutfleisch M, Spital G, Pauleikhoff D (2011) Anti-VEGF therapy of exudative AMD : Prognostic factors for therapy success. Ophthalmologe 108: 124–131PubMedCrossRefGoogle Scholar
  15. Ho J, Sull AC, Vuong LN et al. (2009) Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. Ophthalmology 116: 1960–1970PubMedCrossRefGoogle Scholar
  16. Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE (2001) Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42: 1051–1056PubMedGoogle Scholar
  17. Holz FG, Bellmann C, Margaritidis M, Schutt F, Otto TP, Volcker HE (1999) Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 237: 145–152PubMedCrossRefGoogle Scholar
  18. Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP, Schmitz-Valckenberg S (2007) Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol 143: 463–472PubMedCrossRefGoogle Scholar
  19. Jonas J, Paques M, Mones J, Glacet-Bernard A (2010) Retinal vein occlusions. Dev Ophthalmol 47: 111–135PubMedCrossRefGoogle Scholar
  20. Kellner U, Kellner S (2009) Clinical findings and diagnostics of cone dystrophy. Ophthalmologe 106: 99–108PubMedCrossRefGoogle Scholar
  21. Kellner U, Kellner S, Weinitz S (2010) Fundus autofluorescence (488 NM) and near-infrared autofluorescence (787 NM) visualize different retinal pigment epithelium alterations in patients with age-related macular degeneration. Retina 30: 6–15PubMedCrossRefGoogle Scholar
  22. Liakopoulos S, Ongchin S, Bansal A et al. (2008) Quantitative optical coherence tomography findings in various subtypes of neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 49: 5048–5054PubMedCrossRefGoogle Scholar
  23. Mandecka A, Dawczynski J, Blum M et al. (2007) Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 30: 3048–3052PubMedCrossRefGoogle Scholar
  24. McBain VA, Townend J, Lois N (2007) Fundus autofluorescence in exudative age-related macular degeneration. Br J Ophthalmol 91: 491–496PubMedCrossRefGoogle Scholar
  25. Meyer CH, Helb HM, Eter N (2008) Monitoring of AMD patients on Anti-Vascular Endothelial Growth Factor (VEGF) Treatment: Practial notes on functional and anatomical examination parameters from Drug approval studies, specialist information and case series. Ophthalmologe 105: 125–142PubMedCrossRefGoogle Scholar
  26. Mirshahi A, Lorenz K, Kramann C, Stoffelns B, Hattenbach LO (2011) Ophthalmologic diagnostic procedures and imaging of retinal vein occlusions. Ophthalmologe 108: 111–116PubMedCrossRefGoogle Scholar
  27. Park SJ, Woo SJ, Park KH, Hwang JM, Chung H (2010) Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 51: 3673–3679PubMedCrossRefGoogle Scholar
  28. Pauleikhoff D, Kirchhof B, Bertram B et al. (2009) Aktuelle Ergänzungsstellungnahme der Retinologischen Gesellschaft, des BVA und der DOG: Aspekte in der Therapie der neovaskulären altersabhängigen Makuladegeneration: Kriterien der Wiederbehandlung bei der Anti-VEGF-Therapie.
  29. Puche N, Querques G, Benhamou N et al. (2010) High-resolution spectral domain optical coherence tomography features in adult onset foveomacular vitelliform dystrophy. Br J Ophthalmol 94: 1190–1196PubMedCrossRefGoogle Scholar
  30. Sayegh RG, Georgopoulos M, Geitzenauer W, Simader C, Kiss C, Schmidt-Erfurth U (2010) High-resolution optical coherence tomography after surgery for vitreomacular traction: a 2-year follow-up. Ophthalmology 117: 2010–2017PubMedCrossRefGoogle Scholar
  31. Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF (2008) Fundus autofluorescence imaging: review and perspectives. Retina 28: 385–409PubMedCrossRefGoogle Scholar
  32. Spaide RF (2003) Fundus autofluorescence and age-related macular degeneration. Ophthalmology 110: 392–399PubMedCrossRefGoogle Scholar
  33. Tikellis G, Anuradha S, Klein R, Wong TY (2010) Association between physical activity and retinal microvascular signs: the Atherosclerosis Risk in Communities (ARIC) Study. Microcirculation 17: 381–393PubMedGoogle Scholar
  34. Trieschmann M, Beatty S, Nolan JM et al. (2007) Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 84: 718–728PubMedCrossRefGoogle Scholar
  35. Trieschmann M, Heimes B, Hense HW, Pauleikhoff D (2006) Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol 244: 1565–1574PubMedCrossRefGoogle Scholar
  36. Trieschmann M, Spital G, Lommatzsch A et al. (2003) Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol 241: 1006–1012PubMedCrossRefGoogle Scholar
  37. Vaclavik V, Vujosevic S, Dandekar SS, Bunce C, Peto T, Bird AC (2008) Autofluorescence imaging in age-related macular degeneration complicated by choroidal neovascularization: a prospective study. Ophthalmology 115: 342–346PubMedCrossRefGoogle Scholar
  38. Voigt M, Querques G, Atmani K et al. (2010) Analysis of retinal flecks in fundus flavimaculatus using high-definition spectral-domain optical coherence tomography. Am J Ophthalmol 150: 330–337PubMedCrossRefGoogle Scholar
  39. Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F (2006) Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Invest Ophthalmol Vis Sci 47: 3044–3051PubMedCrossRefGoogle Scholar
  40. Zeimer MB, Kromer I, Spital G, Lommatzsch A, Pauleikhoff D (2010) Macular telangiectasia: patterns of distribution of macular pigment and response to supplementation. Retina 30: 1282–1293PubMedCrossRefGoogle Scholar
  41. Zeimer MB, Padge B, Heimes B, Pauleikhoff D (2010) Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations. Retina 30: 586–595PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2011

Authors and Affiliations

  1. 1.AugenabteilungSt. Franziskus-Hospital MünsterMünster

Personalised recommendations